Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterocyclic amines (HCAs) are a class of potent mutagenic and carcinogenic chemical compounds formed when muscle meat, such as beef, pork, poultry, or fish, is cooked using high-temperature methods like pan-frying or grilling (National Cancer Institute, 2020). These substances are not therapeutic targets; rather, they are exogenous pro-carcinogens that require metabolic bioactivation within the host to exert toxic effects (IARC, 1993). The primary activation pathway involves N-oxidation by hepatic cytochrome P450 1A2 (CYP1A2), followed by esterification by phase II enzymes such as N-acetyltransferases (NAT) or sulfotransferases (SULT), resulting in highly reactive electrophilic intermediates (Turesky & Le Marchand, 2011; UniProt P05177). These reactive species form stable covalent adducts with DNA, particularly at guanine residues, which can lead to mutations in critical tumor suppressor genes and oncogenes like TP53 and KRAS (PubMed, PMC2847610). Epidemiological and experimental evidence strongly links high dietary HCA exposure to an increased risk of several human malignancies, including colorectal, prostate, and breast cancers (NIH, 2020). Consequently, HCAs are of significant concern in toxicology and public health, with research focusing on individual genetic susceptibility and dietary prevention strategies rather than pharmaceutical modulation (PubMed, 22107498).
Not applicable as a therapeutic target; these compounds act as pro-carcinogens that are metabolically activated to form DNA-reactive electrophiles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterocyclic amines (HCA).